🔗 Permalink

Inventor profile of:

Hans-Michael Wolff

City:

Monheim

Country:

Germany

Published Applications:

Last publication date:

2022-09-22

Top Assignees for applications by Hans-Michael Wolff

The entities that hold a legal rights for patent applications filed by inventor Wolff Hans-Michael:

UCB PHARMA GMBH 16 Monheim, Germany
LTS LOHMANN THERAPIE-SYSTEME AG 8 Andernach, Germany
SCHWARZ PHARMA AG 3 Monheim Am Rhein, Germany
LTS LOHMANN THERAPIE-SYSTEME AG 1 Andemach, Germany
Lohmann Therapie-Systeme AG 1 Andernach, Germany
Schwarz Pharma 1 Monheim Am Rhein, Germany
SCHWARZ PHARMA AG 1 Monheim, Germany

Recent patent applications by Wolff Hans-Michael

Hans-Michael Wolff from Monheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-22

US20220296531A1

Human necessities

Method for adjusting the release of active agent in a transdermal delivery system

#2 | 2022-05-19

US20220151949A1

Human necessities

Multi-Day Patch for the Transdermal Administration of Rotigotine

#3 | 2019-10-17

US20190314294A1

Human necessities

Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine

#4 | 2018-09-20

US20180263921A1

Human necessities

Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine

#5 | 2018-05-31

US20180147154A1

Human necessities

Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine

#6 | 2017-03-23

US20170079932A1

Human necessities

Method for adjusting the release of active agent in a transdermal delivery system

#7 | 2015-10-15

US20150290142A1

Human necessities

Multi-day patch for the transdermal administration of rotigotine

#8 | 2014-08-28

US20140243386A1

Human necessities

Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis

#9 | 2012-12-20

US20120322845A1

Human necessities

Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine

#10 | 2012-08-23

US20120215185A1

Human necessities

Transdermal delivery system for the administration of rotigotine

#11 | 2012-08-21

US10627990

Transdermal delivery system

#12 | 2012-07-03

US10630633

Hot-melt TTS for administering rotigotine

#13 | 2012-04-26

US20120101146A1

Human necessities

Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresis

#14 | 2010-12-09

US20100311806A1

Chemistry; metallurgy

Polymorphic form of rotigotine and process for production

#15 | 2009-12-15

US10713424

Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease

#16 | 2009-11-05

US20090274761A1

Human necessities

Transdermal delivery of (R)-3,3-diphenylpropylamin-monoestern

#17 | 2009-06-04

US20090143460A1

Chemistry; metallurgy

Polymorphic form of rotigotine and process for production

#18 | 2009-01-08

US20090012159A1

Chemistry; metallurgy

High purity bases of 3,3-diphenylpropylamino monoesters

#19 | 2006-11-23

US20060263419A1

Human necessities

Transdermal therapeutic system for Parkinson's Disease

#20 | 2006-09-28

US20060216336A1

Human necessities

Transdermal therapeutic system for Parkinson's Disease

#21 | 2006-02-09

US20060029673A1

Human necessities

Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters

#22 | 2006-01-19

US20060014832A1

Chemistry; metallurgy

Highly pure bases of 3,3-dipheyl propylamine monoesters

#23 | 2005-11-24

US20050260254A1

Human necessities

Hot melt TTS for administering rotigotine

#24 | 2005-04-14

US20050079206A1

Human necessities

Transdermal delivery system for the administration of rotigotine

InventorID:

889977 ⎘